Innovate Retina

START-END Oct 8, 2026 from 3:04 PM to 7:15 PM CEST

Session 1: Inherited Retinal Diseases (IRD)
Title: What Is Coming to the Clinics: Tinlarebant for Stargardt Disease
Presenter: Paul Bernstein, MD, PhD, Professor of Ophthalmology and Vice-Chair for Clinical and Basic Science Research at the Moran Eye Center, University of Utah
Date and Time: October 8, 2026 3:04 – 3:07 p.m. CST
Location: InterContinental New Orleans, Salle A-C Ballroom (3rd floor)
Session 7: Industry Insights & Advanced Therapeutics (Non-CME)
Title: Panel Discussion
Panel Members include Hendrik P. N. Scholl, MD, MA, Chief Medical Officer at Belite Bio, Inc, Adjunct Professor at the Department of Clinical Pharmacology, Medical University of Vienna (Vienna, Austria); Senior Consultant at Pallas Klinik Zürich, Pallas Kliniken AG (Zürich, Switzerland); and President of the European Vision Institute (Basel, Switzerland).
Date and Time: October 8, 2026, 6:45 – 7:15 p.m. CST
Moderators: Stephen Smith, MD and Wiley Chambers, MD
Location: InterContinental New Orleans, Salle A-C Ballroom (3rd floor)

Join our mailing list.

 

Sign up to receive important updates and news from Belite Bio